Siegel R.L. Miller K.D. Fuchs H.E. et al.

Cancer Statistics, 2021.

CA: a Cancer J clinicians. 71: 7-33Thomassin-Naggara I. Bazot M. Daraï E. et al.

Epithelial ovarian tumors: value of dynamic contrast-enhanced mr imaging and correlation with tumor angiogenesis.

Radiology. 248: 148-159Javadi S. Ganeshan D.M. Qayyum A. et al.

Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging.

AJR Am J roentgenology. 206: 1351-1360Expert Panel on Women’s I. Kang S.K. Reinhold C. et al.

Acr appropriateness criteria® staging and follow-up of ovarian cancer.

J Am Coll Radiol. 15: S198-S207Masch W.R. Daye D. Lee S.I.

MR Imaging for Incidental Adnexal Mass Characterization.

Magn Reson Imaging Clin N Am. 25: 521-543Chandrashekhara S.H. Thulkar S. Srivastava D.N. et al.

Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer.

Br J Radiol. 84: 38-43Rettenmaier N.B. Rettenmaier C.R. Wojciechowski T. et al.

The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review.

Br J Cancer. 103: 1657-1662

2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.

Gynecol Oncol. 133: 401-404

Staging classification for cancer of the ovary, fallopian tube, and peritoneum.

Int J Gynaecol Obstet official Organ Int Fed Gynaecol Obstet. 124: 1-5Tempany C.M. Zou K.H. Silverman S.G. et al.

Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group.

Radiology. 215: 761-767Atri M. Alabousi A. Reinhold C. et al.

ACR Appropriateness Criteria(®) Clinically Suspected Adnexal Mass, No Acute Symptoms.

J Am Coll Radiol. 16: S77-S93

Rendi MH. Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: histopathology. In: Post TW editor. UpToDate. UpToDate; 2021. Available at: https://www.uptodate.com/contents/epithelial-carcinoma-of-the-ovary-fallopian-tube-and-peritoneum-histopathology. Accessed July 3, 2021.

Bent C.L. Sahdev A. Rockall A.G. et al.

MRI appearances of borderline ovarian tumours.

Clin Radiol. 64: 430-438

Imaging and differential diagnosis of ovarian cancer.

Semin Ultrasound CT MR. 40: 302-318Sohaib S.A. Mills T.D. Sahdev A. et al.

The role of magnetic resonance imaging and ultrasound in patients with adnexal masses.

Clin Radiol. 60: 340-348

MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.

AJR Am J roentgenology. 194: 311-321Tanaka Y.O. Yoshizako T. Nishida M. et al.

Ovarian carcinoma in patients with endometriosis: MR imaging findings.

AJR Am J roentgenology. 175: 1423-1430Davarpanah A.H. Kambadakone A. Holalkere N.S. et al.

Diffusion MRI of uterine and ovarian masses: identifying the benign lesions.

Abdom Radiol. 41: 2466-2475Zhao S.H. Qiang J.W. Zhang G.F. et al.

Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.

Eur Radiol. 24: 2292-2299Jung S.E. Lee J.M. Rha S.E. et al.

Ct and mr imaging of ovarian tumors with emphasis on differential diagnosis.

RadioGraphics. 22: 1305-1325Foti P.V. Attinà G. Spadola S. et al.

MR imaging of ovarian masses: classification and differential diagnosis.

Insights Imaging. 7: 21-41Desai A. Xu J. Aysola K. et al.

Epithelial ovarian cancer: An overview.

World J Transl Med. 3: 1-8Elsherif S. Javadi S. Viswanathan C. et al.

Low-grade epithelial ovarian cancer: what a radiologist should know.

BJR. 92: 20180571Skírnisdóttir I. Garmo H. Wilander E. et al.

Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.

Int J Cancer. 123: 1897-1901Bodurka D.C. Deavers M.T. Tian C. et al.

Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.

Cancer. 118: 3087-3094Zeppernick F. Meinhold-Heerlein I.

The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.

Arch Gynecol Obstet. 290: 839-842Meinhold-Heerlein I. Fotopoulou C. Harter P. et al.

The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.

Arch Gynecol Obstet. 293: 695-700Nik N.N. Vang R. Shih Ie M. et al.

Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.

Annu Rev Pathol. 9: 27-45Köbel M. Kalloger S.E. Huntsman D.G. et al.

Differences in tumor type in low-stage versus high-stage ovarian carcinomas.

Int J Gynecol Pathol : official J Int Soc Gynecol Pathol. 29: 203-211

What's new in gynecologic pathology 2021: ovary and fallopian tube.

J Pathol Translational Med. 55: 366-367

Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.

Ann Oncol : official J Eur Soc Med Oncol. 24: x16-x21Ganeshan D. Bhosale P. Wei W. et al.

Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer.

Abdom Radiol. 41: 1589-1595WHO Classification of Tumours Editorial Board

Female genital tumours.

International Agency for Research on Cancer, Lyon (France) ()Ali R.H. Seidman J.D. Luk M. et al.

Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.

Int J Gynecol Pathol : official J Int Soc Gynecol Pathol. 31: 499-506

Pathology of ovarian carcinoma.

Hematology/Oncology Clin North America. 17 (): 909-925Mangili G. Bergamini A. Taccagni G. et al.

Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.

Gynecol Oncol. 126: 403-407Duska L.R. Garrett L. Henretta M. et al.

When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.

Gynecol Oncol. 116: 374-377Takahama J. Ascher S.M. Hirohashi S. et al.

Borderline Brenner tumor of the ovary: MRI findings.

Abdom Imaging. 29: 528-530Moon W.J. Koh B.H. Kim S.K. et al.

Brenner tumor of the ovary: CT and MR findings.

J Comput Assist tomography. 24: 72-76Takeuchi M. Matsuzaki K. Sano N. et al.

Malignant Brenner tumor with transition from benign to malignant components: computed tomographic and magnetic resonance imaging findings with pathological correlation.

J Comput Assist tomography. 32: 553-554Saida T. Mori K. Tanaka Y.O. et al.

Carcinosarcoma of the ovary: MR and clinical findings compared with high-grade serous carcinoma.

Jpn J Radiol. 39: 357-366Thomassin-Naggara I. Aubert E. Rockall A. et al.

Adnexal masses: development and preliminary validation of an MR imaging scoring system.

Radiology. 267: 432-443Basha M.A.A. Abdelrahman H.M. Metwally M.I. et al.

Validity and Reproducibility of the ADNEX MR Scoring System in the Diagnosis of Sonographically Indeterminate Adnexal Masses.

J Magn Reson Imaging : JMRI. 53: 292-304Reinhold C. Rockall A. Sadowski E.A. et al.

Ovarian-adnexal reporting lexicon for mri: a white paper of the acr ovarian-adnexal reporting and data systems mri committee.

J Am Coll Radiol. 18: 713-729Adusumilli S. Hussain H.K. Caoili E.M. et al.

MRI of sonographically indeterminate adnexal masses.

AJR Am J roentgenology. 187: 732-740

Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid.

Cancer. 46: 2019-2034Yamashita Y. Hatanaka Y. Takahashi M. et al.

Struma ovarii: MR appearances.

Abdom Imaging. 22: 100-102Park S.B. Kim J.K. Kim K.R. et al.

Imaging findings of complications and unusual manifestations of ovarian teratomas.

RadioGraphics. 28: 969-983Ghafoor S. Lakhman Y. Park K.J. et al.

Polypoid endometriosis: a mimic of malignancy.

Abdom Radiol. 45: 1776-1782Mansour S.M. Saraya S. El-Faissal Y.

Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?.

Br J Radiol. 88: 20150099McDermott S. Oei T.N. Iyer V.R. et al.

MR imaging of malignancies arising in endometriomas and extraovarian endometriosis.

RadioGraphics. 32: 845-863